arrow
C

Christina T. Teng

scientia clinical research
H指数:40
被引数:5,165

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLER

早期肿瘤学临床试验中健康相关生活质量的预期性评估:PEARLER

2025-12-010
OAAI
INTERROGATE-GBM Phase I trial: Immunotherapy peptide vaccine targeting cytomegalovirus (CMV) antigens in glioblastoma

INTERROGATE-GBM Ⅰ期临床试验:针对巨细胞病毒(CMV)抗原的胶质母细胞瘤免疫治疗肽疫苗

2025-11-010
OAAI
A phase Ia study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors

一种新型anti-HER2抗体药物偶联物GQ1001在先前治疗过的HER2阳性晚期实体瘤患者中的Ia期研究

2025-01-090
OAAI
A phase I, first-in-human, dose escalation and expansion study of oral pan-RAF/MEK molecular glue NST-628 in subjects with solid tumors harboring RAS-MAPK pathway alterations

一项I期、首次人体、剂量递增和扩展研究,评估口服泛RAF/MEK分子胶NST-628在携带RAS-MAPK通路异常的实体瘤受试者中的效果。

2024-09-010
PRE
Differential in Vitro Biological Action, Coregulator Interactions, and Molecular Dynamic Analysis of Bisphenol A (BPA), BPAF, and BPS Ligand-ERα Complexes

双酚a (BPA),BPAF和BPS配体-er α 配合物的体外生物作用,Coregulator相互作用和分子动力学分析

2018-01-1670
OAAI